ZZ Biotech LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2006-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.zzbiotech.com
Efficacy and Safety Evaluation of 3K3A-APC in Ischemic Stroke
- First Posted Date
- 2022-08-02
- Last Posted Date
- 2024-09-30
- Lead Sponsor
- ZZ Biotech, LLC
- Target Recruit Count
- 1400
- Registration Number
- NCT05484154
Safety Evaluation of 3K3A-APC in Ischemic Stroke
Phase 2
Completed
- Conditions
- Ischemic Stroke
- Interventions
- Biological: 3K3A-APCDrug: Placebo
- First Posted Date
- 2014-08-21
- Last Posted Date
- 2018-11-08
- Lead Sponsor
- ZZ Biotech, LLC
- Target Recruit Count
- 110
- Registration Number
- NCT02222714
- Locations
- 🇺🇸
Stroke Center, Charlottesville, Virginia, United States
Safety and Pharmacokinetics of Single and Multiple Ascending Doses of 3K3A-APC in Healthy Adult Volunteers
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Biological: 3K3A-APC, diluted in 0.9% sodium chloride in waterDrug: 0.9% NaCl in water
- First Posted Date
- 2012-08-08
- Last Posted Date
- 2018-02-05
- Lead Sponsor
- ZZ Biotech, LLC
- Target Recruit Count
- 64
- Registration Number
- NCT01660230
- Locations
- 🇦🇹
Privatklinik Leech, Graz, Austria
© Copyright 2025. All Rights Reserved by MedPath